Published in Hypertension on December 30, 2013
The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease. Transl Res (2014) 0.88
Antihypertensive mechanisms of intra-renal dopamine. Curr Opin Nephrol Hypertens (2015) 0.87
MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells. Hypertension (2015) 0.82
The long noncoding RNA landscape in hypoxic and inflammatory renal epithelial injury. Am J Physiol Renal Physiol (2015) 0.78
Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Gα12. Transplantation (2015) 0.77
Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function. Am J Physiol Renal Physiol (2015) 0.77
Signaling pathways involved in renal oxidative injury: role of the vasoactive peptides and the renal dopaminergic system. J Signal Transduct (2014) 0.75
Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity. PLoS One (2016) 0.75
Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Chronic kidney disease: effects on the cardiovascular system. Circulation (2007) 6.19
The logic of TGFbeta signaling. FEBS Lett (2006) 5.26
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet (2003) 4.63
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem (2003) 4.55
TGF-beta signaling in renal disease. J Am Soc Nephrol (2002) 4.21
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry (1999) 2.90
Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry (1991) 2.30
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol (2006) 1.95
TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. J Am Soc Nephrol (2008) 1.71
Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol (2009) 1.45
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest (2011) 1.38
RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells. J Biol Chem (2009) 1.18
Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension (2006) 1.15
Critical role of CXCL16 in hypertensive kidney injury and fibrosis. Hypertension (2013) 1.13
ALFRED: an allele frequency resource for research and teaching. Nucleic Acids Res (2011) 1.12
The role of oxidative stress in chronic kidney disease. Semin Dial (2009) 1.12
Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension (2001) 1.09
Mechanisms of kidney fibrosis and the role of antifibrotic therapies. Curr Opin Nephrol Hypertens (2009) 1.09
Integrating human and rodent data to identify the genetic factors involved in chronic kidney disease. J Am Soc Nephrol (2010) 1.06
Dopamine and renal function and blood pressure regulation. Compr Physiol (2011) 1.06
Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. JAMA (2010) 1.03
An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. Int J Cardiol (2005) 0.97
Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension (2000) 0.96
Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. Am J Physiol Renal Physiol (2011) 0.95
Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum (2001) 0.93
Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells. Am J Physiol Cell Physiol (2011) 0.92
Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol (2012) 0.91
Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One (2012) 0.90
Constitutive activity of a chimeric D2/D1 dopamine receptor. Mol Pharmacol (1997) 0.89
Isolation, growth, and characterization of human renal epithelial cells using traditional and 3D methods. Methods Mol Biol (2013) 0.88
Dopamine is metabolised by different enzymes along the rat nephron. Pflugers Arch (2005) 0.87
Unravelling the genetic basis of renal diseases; from single gene to multifactorial disorders. J Pathol (2010) 0.86
Anti-inflammatory activity of pergolide, a dopamine receptor agonist. J Pharmacol Exp Ther (1991) 0.81
Differential effects of AGS3 expression on D(2L) dopamine receptor-mediated adenylyl cyclase signaling. Cell Mol Neurobiol (2013) 0.81
Genome sequence and analysis of the tuber crop potato. Nature (2011) 7.77
Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol (2006) 5.00
Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol (2008) 3.13
The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis (2004) 2.86
Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer. Cancer Res (2010) 2.27
Short telomeres and prognosis of hypertension in a chinese population. Hypertension (2009) 2.18
The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol (2007) 2.13
c-Maf regulates IL-10 expression during Th17 polarization. J Immunol (2009) 1.99
G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A (2002) 1.87
Multilocus analysis of hypertension: a hierarchical approach. Hum Hered (2004) 1.82
The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol (2005) 1.75
SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS One (2011) 1.70
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation (2005) 1.69
Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol (2005) 1.64
Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions. Kidney Int (2008) 1.63
Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan. Antimicrob Agents Chemother (2012) 1.60
Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis. Hypertension (2013) 1.57
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest (2010) 1.55
A comparison of the natriuretic and kaliuretic effects of cicletanine and hydrochlorothiazide in prehypertensive and hypertensive humans. J Hypertens (2012) 1.52
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol (2014) 1.50
RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation. J Biol Chem (2005) 1.48
Preanalytical errors introduced by sample-transportation systems: a means to assess them. Clin Chem (2011) 1.48
Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol (2008) 1.47
Mucinous carcinoma of the skin, primary, and secondary: a clinicopathologic study of 63 cases with emphasis on the morphologic spectrum of primary cutaneous forms: homologies with mucinous lesions in the breast. Am J Surg Pathol (2005) 1.42
Enhanced de novo assembly of high throughput pyrosequencing data using whole genome mapping. PLoS One (2013) 1.42
Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem Biophys Res Commun (2011) 1.41
Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol (2006) 1.40
Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney. Hypertens Res (2011) 1.40
Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade. Ann Surg (2006) 1.38
A three-step proteolytic cascade mediates the activation of the peptidoglycan-induced toll pathway in an insect. J Biol Chem (2008) 1.37
Anal HPV infection in HIV-positive men who have sex with men from China. PLoS One (2010) 1.37
Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res (2006) 1.36
Functional genomics of the dopaminergic system in hypertension. Physiol Genomics (2004) 1.32
D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol (2006) 1.32
Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology (2008) 1.31
Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest (2008) 1.31
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer. Cancer Chemother Pharmacol (2011) 1.30
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension (2012) 1.30
The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PLoS One (2013) 1.29
Development and preliminary validation of heart rate and breathing rate detection using a passive, ballistocardiography-based sleep monitoring system. IEEE Trans Inf Technol Biomed (2009) 1.29
D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int (2004) 1.28
Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J Allergy Clin Immunol (2004) 1.27
3D cell culture opens new dimensions in cell-based assays. Drug Discov Today (2008) 1.26
Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci (2002) 1.25
catena-Poly[[bis-(μ-2-formyl-6-meth-oxy-phenolato)copper(II)sodium]-μ-nitrato]. Acta Crystallogr Sect E Struct Rep Online (2011) 1.25
Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol (2003) 1.24
Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology (2002) 1.23
Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer (2009) 1.23
Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension (2006) 1.22
Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension (2005) 1.22
Genetics of salt-sensitive hypertension. Curr Hypertens Rep (2011) 1.21
Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens (2013) 1.21
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol (2007) 1.21
Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension (2006) 1.20
Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene (2004) 1.20
Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem (2002) 1.20
RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells. J Biol Chem (2009) 1.18
Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension (2003) 1.17
Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension (2003) 1.16
Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int (2002) 1.16
High-performance transparent inorganic-organic hybrid thin-film n-type transistors. Nat Mater (2006) 1.16
Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells. J Biol Chem (2007) 1.16
Lysophosphatidic acid induces MDA-MB-231 breast cancer cells migration through activation of PI3K/PAK1/ERK signaling. PLoS One (2010) 1.16
Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension (2006) 1.15
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol (2009) 1.15
Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol Gastrointest Liver Physiol (2003) 1.15
Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta (2010) 1.13
Estrogen upregulates renal angiotensin II AT1 and AT2 receptors in the rat. Regul Pept (2005) 1.11
Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension (2008) 1.11
Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-κB-mediated mechanism. Proc Natl Acad Sci U S A (2013) 1.11
Human papillomavirus infection and laryngeal cancer risk: a systematic review and meta-analysis. J Infect Dis (2012) 1.11
Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr (2010) 1.11